MedPath

Prospective study to assess the association of the treatment outcomes and the quality of life in advanced urothelial carcinoma

Not Applicable
Conditions
Metastatic Urothelial Carcinoma
Registration Number
JPRN-UMIN000046249
Lead Sponsor
Osaka Medical and Pharmaceutical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

cognitive function decline

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath